Articles Tagged With:
-
Research Community Seeks to Enroll More Minorities in Clinical Trials
Several months of data from the COVID-19 pandemic showed that African Americans and other people of color were disproportionately dying from the disease. Disparities in how COVID-19 affects minority communities highlight long-standing difficulties in achieving health equity in U.S. society, including clinical trials.
-
Understanding Cannabidiol (CBD)
Cannabidiol is used by a growing population for many ailments. Although not typically an emergency drug, it has important interactions and a few side effects that can be seen in the emergency department.
-
Study: No Relationship Between Blood Type, COVID-19 Severity
But those with certain blood types may be at higher risk for testing positive.
-
White Paper Calls for Overhaul of Federal Nutrition Research
Coalition of experts say extra funding, better coordination needed to improve public health.
-
Protect the Brain from Air Pollution with … Fish?
Researchers observed better white matter preservation in those who consumed more omega-3 fatty acids.
-
Stroke Risk and Social Determinants of Health
Income levels, health insurance access among several factors researchers connected to incident stroke events.
-
We’d Love to Hear from You!
Please complete our annual reader survey (https://bit.ly/2XYHWdM).
-
The ABCs of CBD: The Fundamentals of Cannabidiol
Cannabidiol (CBD) is one of two major constituents of marijuana and is the non-psychoactive component of cannabis. As its popularity has grown, questions about CBD from patients to their primary care clinicians have increased dramatically. As a patient advocate interpreting the available evidence, the primary care clinician needs to recognize how CBD differs from marijuana, what its clinical utility might be, and what its risks are.
-
We’d Love to Hear from You!
Annual Reader Survey -
Infectious Disease Alert Updates
Metronidazole Neurotoxicity Is Real; 2020 Updated LTBI Treatment Guidelines; Risks of Hookah Smoking